BMB Reports : eISSN 1976-670X

Cited by CrossRef (14)

  1. Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, Giovanna Motta, Elena Sabattini, Alessandro Pileri. The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets. Cells 2024;13:584
  2. Wei Song, Haixi Zhang, Fan Yang, Kiichi Nakahira, Cheng Wang, Keqian Shi, Ruoyu Zhang. Single cell profiling of γδ hepatosplenic T-cell lymphoma unravels tumor cell heterogeneity associated with disease progression. Cell Oncol. 2023;46:211
  3. Yenddy N. Carrero, Diana E. Callejas, Jesús A. Mosquera. In situ immunopathological events in human cervical intraepithelial neoplasia and cervical cancer: Review. Translational Oncology 2021;14:101058
  4. Yuanyuan Li, Zhongyan Wang. Interleukin 32 participates in cardiomyocyte‑induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway. Exp Ther Med 2022;24
  5. Lifeng Shang, Xinli Chen, Tianyu Zhu, Shujing Chong, Haiwang Liu, Wei Huang, Weibo Fu, Hao She, Xin Shen. Cancer-Associated Fibroblast-Secreted Exosomes Promote Gastric Cancer Cell Migration and Invasion via the IL-32/ESR1 Axis. Appl Biochem Biotechnol 2024
  6. Dorota Diakowska, Małgorzata Krzystek-Korpacka. Local and Systemic Interleukin-32 in Esophageal, Gastric, and Colorectal Cancers: Clinical and Diagnostic Significance. Diagnostics 2020;10:785
  7. S. K. Daniel, K. M. Sullivan, L. K. Dickerson, R. J. E. van den Bijgaart, A. F. Utria, K. P. Labadie, H. L. Kenerson, X. Jiang, K. S. Smythe, J. S. Campbell, R. H. Pierce, T. S. Kim, K. J. Riehle, R. S. Yeung, J. A. Carter, K. C. Barry, V. G. Pillarisetty. Reversing immunosuppression in the tumor microenvironment of fibrolamellar carcinoma via PD-1 and IL-10 blockade. Sci Rep 2024;14
  8. Jana Plava, Monika Burikova, Marina Cihova, Lenka Trnkova, Bozena Smolkova, Pavel Babal, Lucia Krivosikova, Pavol Janega, Lucia Rojikova, Slavka Drahosova, Martin Bohac, Lubos Danisovic, Lucia Kucerova, Svetlana Miklikova. Chemotherapy-triggered changes in stromal compartment drive tumor invasiveness and progression of breast cancer. J Exp Clin Cancer Res 2021;40
  9. Salomé Decombis, Antonin Papin, Céline Bellanger, Clara Sortais, Christelle Dousset, Yannick Le Bris, Thiphanie Riveron, Stéphanie Blandin, Philippe Hulin, Benoit Tessoulin, Mathieu Rouel, Steven Le Gouill, Agnès Moreau-Aubry, Catherine Pellat-Deceunynck, David Chiron. The IL32/BAFF axis supports prosurvival dialogs in the lymphoma ecosystem and is disrupted by NIK inhibition. haematol 2022;107:2905
  10. Yang Si, Jiwei Zhang, Shisan Bao, Steven G. Wise, Yuli Wang, Yanfang Zhang, Yuhong Tang. IL-32 and IL-34 in hepatocellular carcinoma. Front. Med. 2022;9
  11. Shashank Kumar Maurya, Neetu Bhattacharya, Amit Bhattacharya, Sabysachi Senapati. Obesity and Cancer. 2022.
  12. Mohammad Fereydouni, Elnaz Ahani, Parth Desai, Mona Motaghed, Anthony Dellinger, Dean D. Metcalfe, Yuzhi Yin, Sung Hyun Lee, Tal Kafri, Aadra P. Bhatt, Kristen Dellinger, Christopher L. Kepley. Human Tumor Targeted Cytotoxic Mast Cells for Cancer Immunotherapy. Front. Oncol. 2022;12
  13. Etiene Moreira Gabriel, Tomas Raul Wiche Salinas, Annie Gosselin, Etienne Larouche-Anctil, Madeleine Durand, Alan L. Landay, Mohamed El-Far, Cécile L. Tremblay, Jean-Pierre Routy, Petronela Ancuta. Overt IL-32 isoform expression at intestinal level during HIV-1 infection is negatively regulated by IL-17A. 2021;35:1881
  14. Ji Young Kang, Kyung Eun Kim. Prognostic Value of Interleukin-32 Expression and Its Correlation with the Infiltration of Natural Killer Cells in Cutaneous Melanoma. JCM 2021;10:4691